Imperva (IMPV) Tops Q1 EPS by 12c; Guides FY15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/18/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Adobe has received a takeover approach by a Big Tech company - Betaville
- Medifast launches Trilivy, replacing its Optavia brand
Needham & Company Raises PT Sharply as Imperva (IMPV) Raises Guidance
May 8, 2015 6:59 AM EDTNeedham & Company reiterates their Buy rating on Imperva, Inc. (NYSE: IMPV), and raised the price target to $67 (from $48), after a strong, and well above consensuses, March quarter. IMPV reported a revenue of $44.8m (well above $40.5m consensus), and a loss of $0.26 per share was smaller than the $0.38 loss expected. IMPV raised their June quarter consensus to $47-$49m and (0.20) to (0.24), which is... More
Oppenheimer Raises PT After Imperva's (IMPV) Strong 1Q Showing
May 8, 2015 6:38 AM EDTOppenheimer reiterates their Outperform rating on Imperva, Inc. (NYSE: IMPV), and raised their price target to $58 (from $55), after a strong 1Q15.IMPV reported revenue up 42% YoY to $44.8M, which bested Oppenheimer estimates of $40.5M. IMPV also reported a loss per share of $0.26, better than estimated... More
